Introduction
In about 15% of cases of tuberculosis occurring in immune-competent patients, the initial site is extrapulmonary. The sternum is very rare among extrapulmonary sites, accounting for less than 1% of all cases of tuberculous osteomyelitis, even in endemic countries, and falls under the differential diagnosis for chest wall masses [1] [2] [3] [4] .
The origin of sternal tuberculosis is not completely understood. It may be a late complication of pulmonary tuberculosis, or the result of reactivation of a latent focus of primary tuberculosis formed during hematogenous or lymphatic dissemination or of direct extension from mediastinal lymph nodes [5] . Here, we present a case of sternal tuberculosis, and review the literature.
Case
An 84-year-old female patient visited Seoul National University Hospital presenting a 2×3 cm chest wound with sternum exposure (Fig. 1) . Her past medical history included hypertension, diabetes, chronic kidney disease, and asthma, but no immunedeficient diseases. She had also previously received percutaneous coronary intervention for coronary artery occlusive disease.
She had undergone excision of a 3.8×1.8×0.7 cm sized irregular shaped yellowish soft tissue anterior chest mass with fluid collection at the department of thoracic surgery at another hospital about 5 months before. Gram stain and culture study results for the fluid had been negative, and biopsy of the mass had revealed acute and chronic suppurative inflammation. The wound became disrupted with pus discharge 2 months after excision, and the patient underwent debridement and primary closure by the hospital's plastic surgeons. The biopsy results of the secondary surgery presented a cystic lesion with chronic granulomatous inflammation and foreign body reac-tion. Likewise, there were no specific findings in the Gram stain and culture studies. Three months later, the wound was At initial presentation to our institute, the wound did not have a severe odor and displayed only minimal discharge. The patient' s white blood cell count was 10.04×10 3 /µL, erythrocyte sedimentation rate 59 mm/hr and C-reactive protein 3.82 mg/dL. There were no specific findings on simple chest radiographs. Chest computed tomography (CT) revealed no pulmonary or pleural lesions, but suspected mediastinal lymphadenopathy was visible (Fig. 2) . Chest magnetic resonance imaging (MRI) revealed a sternal bone marrow signal corresponding to sternal osteomyelitis (Fig. 3) .
Surgical debridement was performed, including curettage for sternal osteomyelitis to the extent where bone inflammation was visible, followed by negative pressure wound therapy. Biopsies of sternum, soft tissue, and internal mammary lymph nodes all revealed chronic granulomatous inflammation with non-caseating necrosis. Gram and acid-fast bacilli stains were negative, but cultures yielded Mycobacterium tuberculosis. Tuberculosis polymerase chain reaction (PCR) was also positive for M. tuberculosis. Based on these results, oral administration of anti-tuberculosis agents (isoniazid, rifampicin, pyrazinamide, and ethambutol) was started. Immediate flap surgery for coverage of the defect at the time of debridement was considered but decided against, on the reasoning that if the cause of recurrent wound disruption was not precisely known, it would be likely to cause wound problems again after flap coverage. Also, general anesthesia was deemed risky due to the patient's old age and underlying diseases such as coronary artery occlusive disease, hypertension, diabetes, chronic kidney disease, and asthma.
After application of negative pressure wound therapy and administration of anti-tuberculosis agents, the therapeutic reaction was satisfactory, therefore negative pressure therapy was maintained without secondary surgery. Negative pressure wound dressings were regularly changed twice a week and maintained for about 3 weeks, after which granulation tissue had filled up and wound discharge had decreased enough to allow switching to simple dressings. White blood cell count and C-reactive protein levels decreased to 6.25×10 3 /μL and 0.05 mg/dL, respectively. The patient was discharged 1 week after removal of negative pressure wound therapy, and visited the outpatient clinic periodically for wound evaluation and dressing treatment. The wound was totally epithelized 1 month after initiation of oral anti-tuberculosis agents, but the patient was maintained on medication for 6 months.
Discussion
Sternal tuberculosis may cause non-specific clinical features of sternal swelling, pain and erythema, or constitutional symptoms such as fever, night sweat, and weight loss. As reported in several sporadic case reports including this one, it is important to suspect tuberculosis and carry out a diagnostic study if there is a non-resolving infection, or diagnosis can be delayed [5] .
In sternal tuberculosis, the white blood cell count, erythrocyte sedimentation rate, C-reactive protein and lactate dehydrogenase levels are always elevated as in other infections. Thus, it is difficult to diagnose sternal tuberculosis with only laboratory blood tests, and radiologic tests such as CT and MRI may be helpful [1] [2] [3] . CT is the best modality for detecting osteolytic and sclerotic lesions, and MRI can detect early marrow and soft-tissue involvement. Histopathological and microbiological examinations are crucial for definitive diagnosis of sternal tuberculosis [2] . PCR can be helpful because results are obtained quickly and PCR findings are highly correlated with histological findings.
Whether or not surgical intervention is needed to treat sternal tuberculosis has yet to be established [1, 3] . Some reported that the cure rate was approximately 95% with medical therapy only, while others reported that over 25% required concomitant surgical interventions [1] . Medication for sternal tuberculosis is a 6-to 9-month regimen according to the general treatment for extra-pulmonary tuberculosis [6, 7] . The 6-month regimen is the same as the medication for pulmonary tuberculosis, but it can be extended to 9 months for sternal tuberculosis because it is difficult to determine the therapeutic response for bone infections [7] . The patients are given isoniazid, rifampicin, pyrazinamide and ethambutol for 2 months, followed by isoniazid and rifampicin for four to 7 months. In patients with sternal tuberculosis, isolation and identification of patient contacts are not required unless respiratory tuberculosis is present. Since clinical responses precede radiologic responses, therapeutic effectiveness can be evaluated by periodic clinical examination.
Without appropriate and effective management, sternal tuberculosis may lead to complications such as secondary infection, fistula formation, sternal fracture, and compression of large vessels and trachea [8] . M. tuberculosis infection can be relatively easily ruled out by microbiological tests, but if diagnosis is delayed patients can be exposed to unnecessary treatments, resulting in socioeconomic losses. In the present case the diagnosis of sternal tuberculosis was delayed, and the patient underwent repeated revision operations and tests.
Even though the prevalence of sternal tuberculosis is not high, when there is an unresolved infection or a chest wound that does not heal, sternal tuberculosis should be suspected and tests should be performed in order to obtain an early diagnosis and provide appropriate treatment.
